Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: In Vitro Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Sex hormone-binding globulin (SHBG) is a serum protein released mainly by the liver, and a low serum level correlates with a risk for metabolic syndrome including diabetes, obesity, and cardiovascular events. However, the underlying molecular mechanism(s) linking SHBG and metabolic syndrome remains unknown. In this study, using adipocytes and macrophages, we focused on the in vitro effects of SHBG on inflammation as well as lipid metabolism. Incubation with 20 nM SHBG markedly suppressed lipopolysaccharide- (LPS-) induced inflammatory cytokines, such as MCP-1, TNF α , and IL-6 in adipocytes and macrophages, along with phosphorylations of JNK and ERK. Anti-inflammatory effects were also observed in 3T3-L1 adipocytes cocultured with LPS-stimulated macrophages. In addition, SHBG treatment for 18 hrs or longer significantly induced the lipid degradation of differentiated 3T3-L1 cells, with alterations in its corresponding gene and protein levels. Notably, these effects of SHBG were not altered by coaddition of large amounts of testosterone or estradiol. In conclusion, SHBG suppresses inflammation and lipid accumulation in macrophages and adipocytes, which might be among the mechanisms underlying the protective effect of SHBG, that is, its actions which reduce the incidence of metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings lend support to the hypothesis that the increase in SHBG levels induced by liraglutide might contribute per se to reduce the risk of developing the metabolic syndrome in PCOS, also considering the effect of SHBG in directly suppressing inflammation and lipid accumulation in macrophages and adipocytes [65].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23187 · Cited by 272 · cited 1×
“Pepck CTAACTTGGCCATGATGAACC CTTCACTGAGGTGCCAGGAG [31]”
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Acrp30 GCTCCTGCTTTGGTCCCTCCAC GCCCTTCAGCTCCTGTCATTCC [32]”
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889 · cited 1×
“AP-1 regulates MCP-1, a key chemokine for monocyte/macrophage migration and infiltration [51].”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682 · cited 1×
“MCP-1, which is known to be highly expressed in adipocytes, is related to the induction of chronic inflammation [42].”
BackgroundThe family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667 · cited 2×
“AP-1 regulates MCP-1, a key chemokine for monocyte/macrophage migration and infiltration [51].”
BackgroundNile red: a selective fluorescent stain for intracellular lipid droplets.
Greenspan, P., Mayer, E. P., & Fowler, S. D. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.3.965 · Cited by 2,543 · cited 1×
“Nile Red (AdipoRed, Lonza) becomes fluorescent when it is partitioned in a hydrophobic environment and shows selective fluorescence for intracellular lipid droplets [41].”
BackgroundKawai, T., & Akira, S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,810 · cited 2×
“AP-1 regulates MCP-1, a key chemokine for monocyte/macrophage migration and infiltration [51].”
BackgroundThe Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536
Research works printed but not linked: 2
- 2003, Medical Science Monitor, 9, Cr152
- 2005, Clinical Laboratory, 51, 625
Cited by
Qu, X., & Donnelly, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218191 · Cited by 210
“of metabolic syndrome and its complications [64].”
BackgroundMale Obesity-related Secondary Hypogonadism – Pathophysiology, Clinical Implications and Management
Fernandez, C. J., Department of Endocrinology & Metabolism, P. H., Chacko, E. C., Department of Endocrinology, J. G. H., Pappachan, J. M., & Department of Endocrinology & Metabolism, L. T. H. N. F. T. (2019) · European Endocrinology · doi:10.17925/ee.2019.15.2.83 · Cited by 145
“Low SHBG can be the result of insulin resistance.(47)”
BackgroundXing, C., Zhang, J., Zhao, H., & He, B. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s344542 · Cited by 118
“SHBG inhibits inflammation and lipid accumulation in macrophages and adipocytes, which may be a potential mechanism underlying the protective effects of SHBG in reducing the incidence of metabolic syndrome and its complications.(59)”
BackgroundBourebaba, N., Ngo, T., Śmieszek, A., Bourebaba, L., & Marycz, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113261 · Cited by 86
Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
Song, M. J., & Choi, J. Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1053709 · Cited by 74
“Furthermore, SHBG has anti-inflammatory and lipolytic effects on adipocytes and macrophages, which could explain its association with lower incidence rates of metabolic syndrome and its complications (100).”
BackgroundTestosterone, cardiomyopathies, and heart failure: a narrative review
Diaconu, R., Donoiu, I., Mirea, O., & Bălşeanu, T. A. (2021) · Asian Journal of Andrology · doi:10.4103/aja.aja_80_20 · Cited by 57
Male Obesity Associated Gonadal Dysfunction and the Role of Bariatric Surgery
Sultan, S., Patel, A. G., El-Hassani, S., Whitelaw, B., Leca, B. M., Vincent, R. P., le Roux, C. W., Rubino, F., Aywlin, S. J. B., & Dimitriadis, G. K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00408 · Cited by 39
“Sex Hormone Binding Globulin (SHBG) is a glycoprotein produced by the liver.”
BackgroundInfluentialSaez-Lopez, C., Villena, J. A., Simó, R., & Selva, D. M. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108480 · Cited by 38
Zhao, J. V., & Schooling, C. M. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050659 · Cited by 38
Wang, X., Xie, J., Pang, J., Zhang, H., Chen, X., Lin, J.-S., Li, Q., Chen, Q., Ma, J., Xu, X., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz244 · Cited by 39
Biernacka-Bartnik, A., Kocełak, P., Owczarek, A. J., Choręza, P. S., Markuszewski, L., Madej, P., Puzianowska‐Kuźnicka, M., Chudek, J. T., & Olszanecka‐Glinianowicz, M. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1100547 · Cited by 49
Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
Pugliese, G., de Alteriis, G., Muscogiuri, G., Barrea, L., Verde, L., Zumbolo, F., Colao, A., & Savastano, S. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02084-6 · Cited by 29
Osmancevic, A., Daka, B., Michos, E. D., Trimpou, P., & Allison, M. (2023) · Clinical Endocrinology · doi:10.1111/cen.14930 · Cited by 34
“Sex‐hormone binding globulin (SHBG) is a protein carrier with potential biological anti‐inflammatory function, regulating concentrations of testosterone.(9) Low levels of SHBG have been related to increased risk for insulin resistance, obesity, T2DM and metabolic syndrome in men.”
BackgroundLombardo, G., Mondelli, V., Worrell, C., Sforzini, L., Mariani, N., Nikkheslat, N., Nettis, M. A., Kose, M., Zajkowska, Z., Cattaneo, A., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.018 · Cited by 26
Longitudinal associations between sex hormone-binding globulin and insulin resistance
Ottarsdottir, K., Hellgren, M. I., Bock, D., Nilsson, A. G., & Daka, B. (2020) · Endocrine Connections · doi:10.1530/ec-20-0141 · Cited by 26
Cai, X., Thorand, B., Hohenester, S. D., Prehn, C. P., Cecil, A., Adamski, J., Zeller, T., Dennis, A., Banerjee, R., Peters, A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1223162 · Cited by 25
Beyond reproduction: unraveling the impact of sex hormones on cardiometabolic health
Xega, V., & Liu, J. (2024) · Medical Review · doi:10.1515/mr-2024-0012 · Cited by 35
Sex Hormone and Colorectal Cancer: The Knowns and Unknowns
Hang, D., & Shen, H. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0472 · Cited by 20
“Moreover, a low SHBG level is a marker of insulin resistance (16), and experimental evidence suggests that SHBG may suppresses inflammation and lipid accumulation in macrophages and adipocytes (17).”
BackgroundFujihara, Y., Hamanoue, N., Yano, H., Tanabe, M., Akehi, Y., Nomiyama, T., & Yanase, T. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0505 · Cited by 19
Hang, D., He, X., Kværner, A. S., Chan, A. T., Wu, K., Ogino, S., Hu, Z., Shen, H., Giovannucci, E. L., & Song, M. (2021) · BMC Medicine · doi:10.1186/s12916-020-01895-1 · Cited by 27
“In addition to modulating sex hormone balance, in vitro evidence suggests that SHBG may suppresses inflammation and lipid accumulation in macrophages and adipocytes independent of testosterone and estradiol [47].”
BackgroundLiu, N., Feng, Y., Luo, X., Ma, X., & Ma, F. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.802945 · Cited by 22
“SHBG could protect against metabolic syndrome by suppressing inflammation and lipid accumulation in macrophages and adipocytes (20).”
BackgroundUrbano, F., Chiarito, M., Lattanzio, C., Messa, A., Ferrante, M., Francavilla, M., Mehmeti, I., Lassandro, G., Giordano, P., & Faienza, M. F. (2022) · Children · doi:10.3390/children9111748 · Cited by 19
Hypogonadism and nonalcoholic fatty liver disease
Papadimitriou, K., Mousiolis, A. C., Mintziori, G., Tarenidou, C., Pοlyzos, S. A., & Goulis, D. G. (2024) · Endocrine · doi:10.1007/s12020-024-03878-1 · Cited by 19
“Furthermore, SHBG has lipolytic effects on adipocytes and anti-in fl ammatory effects on macrophages [88], which might indicate a potentially protective effect toward metabolic syndrome.”
Stangl, T. A., Wiepjes, C. M., Smit, R. A. J., Vlieg, A. V. H., Lamb, H. J., van der Velde, J. H. P. M., Eekelen, E. W.-V., Boone, S. C., Brouwers, M. C. G. J., Rosendaal, F. R., et al. (2024) · Diabetes · doi:10.2337/db23-0982 · Cited by 24
Endocrine Disorders and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
Betlejewska, J., Hubska, J., Roszkowska, Z., Maciejczyk, A., Bachurska, D., Domański, J., Miarka, M., Raszeja‐Wyszomirska, J., Bobrowicz, M., & Ambroziak, U. (2025) · Biomedicines · doi:10.3390/biomedicines13102500 · Cited by 20
“Additionally, in an in vitro study on macrophages and adipocytes, physiological SHBG concentrations attenuated inflammation and lipid accumulation [122], suggesting that reduced SHBG may favor lipid storage in the liver.”
Ma, Y., Li, R., Zhan, W., Huang, X., Zhou, Y., Sun, Y., Tian, H. M., Zhu, H., & Yin, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.792114 · Cited by 17
“This may be on account of pre-adolescent child sex steroid hormone levels are very low (45, 46).”
BackgroundZhao, J. V., & Schooling, C. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-02510-w · Cited by 14
Persky, V., Abasilim, C., Tsintsifas, K., Day, T., Sargis, R. M., Daviglus, M. L., Cai, J., Freels, S. A., Unterman, T. G., Chávez, N., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad018 · Cited by 19
Peng, R., & Li, Y. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s298270 · Cited by 14
Pranty-Weßelmann, A. I., Wruck, W., & Adjaye, J. (2023) · Cells · doi:10.3390/cells12182277 · Cited by 14
Serum visfatin concentration and its relationship with sex hormones in obese Saudi women.
Alnowihi, S. M., Doghaither, H. A. A., & Osman, N. N. (2020) · PubMed Central · Cited by 17
Bilder, D. A., Worsham, W., SULLIVAN, S. A., Esplin, M. S., Burghardt, P. R., Fraser, A. M., & Bakian, A. V. (2023) · Molecular Autism · doi:10.1186/s13229-023-00562-5 · Cited by 14
Zhao, S., Li, Y., & Su, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1265719 · Cited by 17
Bourebaba, L., Kępska, M., Qasem, B., Zyzak, M., Łyczko, J., Klemens, M., Mularczyk, M., & Marycz, K. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1214961 · Cited by 14
Longitudinal Changes in Sex Hormone–Binding Globulin in Men With HIV
Pena Dias, J., Haberlen, S. A., Dobs, A. S., Lake, J. E., Palella, F. J., Kingsley, L. A., Price, J. C., Basaria, S., Varadhan, R., Margolick, J. B., et al. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002723 · Cited by 11
Liu, H., Lyu, Y., Li, D., Cui, Y., Huang, Y., Dai, W., & Li, Y. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0823-3 · Cited by 11
Li, Y., Hu, L., Zhou, B., Zheng, Z., Xu, Q., Liu, J., Song, L., Wang, Y., & Mei, S. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.138305 · Cited by 10
Fodor, L., Belčić, V., Korbar, A. O., Ćurković, S., Vujičić, B., Gulin, T., Muslim, J., Gulin, M., Grgurević, M., & Ćuti, E. Ć. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247717 · Cited by 12
“According to a recent meta-analysis, low total testosterone levels showed a positive association with MAFLD in men but an inverse relationship in women [29].”
Jain, S. K., Margret, J. J., Abrams, S. A., Levine, S. N., & Bhusal, K. (2024) · Nutrients · doi:10.3390/nu16132004 · Cited by 13
“Studies have concluded that SHBG suppresses inflammation and acts on macrophages, muscles, and adipocytes [123].”
BackgroundHa, M., Yook, J. S., Lee, M. C., Suwabe, K., Jeong, W.-M., Kwak, J.-J., & Soya, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-84301-x · Cited by 13
Dong, J., Liu, C., Lu, J., Wang, L., Xie, S., Ji, L., & Lu, B. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14082 · Cited by 10
Abildgaard, J., Aleliunaite, A., Horváth, C., Palani, N. P., Henriksen, T. I., Zhong, J., Lorentsen, K. M., Svenstrup, V., Frederiksen, H. W., Juul, A., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102189 · Cited by 9
“Furthermore, in vitro studies show an upregulation of proteins regulating lipolysis following SHBG treatment [16,17].”
InfluentialDias, J. P., Piggott, D. A., Sun, J., Wehbeh, L., Garza, J., Abraham, A. G., Astemborski, J. A., Moseley, K. F., Basaria, S. S., Varadhan, R., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac144 · Cited by 6
Lau, L. H. Y., Nano, J., Prehn, C. P., Cecil, A., Rathmann, W., Zeller, T., Lechner, A., Adamski, J., Peters, A., & Thorand, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1000650 · Cited by 13
Sex hormone-binding globulin levels and development of hypertension in middle-aged men and women
Watz, M. E. S., Tivesten, Å., Ottarsdottir, K., Li, Y., Hellgren, M. I., Lindblad, U., & Daka, B. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003506 · Cited by 9
“Keywords: blood pressure, hypertension, prospective study, sex hormone-binding globulin Abbreviations: CI, confidence interval; ESC, European Association of Cardiology; HRT, hormone replacement therapy; IL-6, interleukin 6; JNC 7, The Seventh Report of the Joint National Committee; LTPA, leisure-time physical activity…”
BackgroundInfluentialZhao, Y., Pang, J., Fang, X., Yan, Z., Yang, H., Deng, Q., Ma, T., Lv, M., Li, Y., Tu, Z., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1348368 · Cited by 13
Marro, J., Chetwynd, A. J., Wright, R. D., Dliso, S., & Oni, L. (2022) · Children · doi:10.3390/children9050622 · Cited by 11
“In vitro, SHBG suppresses inflammation in macrophages [31], and it is downregulated by TNF-α [32] and IL-1β [33].”
BackgroundNotbohm, H. L., Umlauff, L., Bloch, W., & Schumann, M. (2023) · European Journal of Applied Physiology · doi:10.1007/s00421-023-05275-4 · Cited by 15
“…oral contraceptive users show increased concentrations of sex-hormone binding globulin (Wiegratz et al. 2003), which has been shown to have an inverse relationship with pro-inflammatory cytokines and anti-inflammatory effects on adipocytes and macrophages (Maggio et al. 2011; Yamazaki et al. 2018).”
BackgroundTransforming growth factor‐beta 1: A new factor reducing hepatic SHBG production in liver fibrosis
Briansó‐Llort, L., Fuertes‐Rioja, L., Ramos‐Perez, L., Salcedo, M. T., Hernández, C., Simó, R., & Selva, D. M. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30818 · Cited by 10
“Since recent results have shown that SHBG can regulate lipogenesis and inflammation (Saez‐Lopez et al., 2017, 2019; Yamazaki et al., 2018) it is plausible that TGF‐β1 altered levels leading to the development of T2D, CVD, and hepatic steatosis might partially be mediated through”
ResultSingh, P., Covassin, N., Kuniyoshi, F. H. S., Marlatt, K. L., Romero‐Corral, A., Davison, D. E., Singh, R. J., Jensen, M. D., & Somers, V. K. (2021) · Physiological Reports · doi:10.14814/phy2.15127 · Cited by 8
“SHBG is also demonstrated to have direct lipolytic and antiinflammatory action in adipose tissue and macrophages (SaezLopez et al., 2020; Yamazaki et al., 2018).”
BackgroundLiu, Q., Zhao, Y., Gu, Y., Shang, X., Zhou, Y., Zhang, H., Zuo, L., Mei, G., Li, H., Xiong, C., et al. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104040 · Cited by 7
Dong, Y. C., Li, Y., Ma, L., Shu, S., Ren, J., Yu, X., Luo, D., Duan, Z., & Yu, Y. (2024) · Toxics · doi:10.3390/toxics12080600 · Cited by 7
“…inflammation and lipid accumulation in macrophages and adipocytes, and the addition of testosterone or estradiol does not alter these effects of SHBG [51], which may suggest that high SHBG reduces the risk of glycemic disorder caused by glyphosate by inhibiting obesity-associated inflammation.”
BackgroundBourebaba, L., Zyzak, M., Sikora, M., Serwotka-Suszczak, A. M., Mularczyk, M., Naem, M. A., & Marycz, K. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10580-8 · Cited by 8
Marycz, K., Wiatrak, B., Houston, J. M. I., Marcinkowska, K. A., Mularczyk, M., & Bourebaba, L. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02459-z · Cited by 7
Liu, S., Mu, Z., Chen, X., & Xu, Y. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01443-4 · Cited by 8
SHBG, Free Testosterone, and Type 2 Diabetes Risk in Middle-aged African Men: A Longitudinal Study
Seipone, I. D., Mendham, A. E., Storbeck, K., Oestlund, I., Kufe, C. N., Chikowore, T., Masemola, M., Crowther, N. J., Kengne, A. P., Norris, S. A., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae129 · Cited by 7
“These functions could be pivotal in the protective capacity of SHBG, contributing to its ability to lower the risk of metabolic syndrome [54].”
BackgroundLee, S. R., Kim, N. R., Mukae, M., Won, Y. S., & Hong, E. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00747.2024 · Cited by 6
Huang, R., Wang, Y., Yan, R., Ding, B., & Ma, J. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01445-x · Cited by 9
Sex Hormone-Binding Globulin and Metabolic Syndrome in Children and Adolescents: A Focus on Puberty
Aydın, B. K., & Winters, S. J. (2025) · Metabolites · doi:10.3390/metabo15080494 · Cited by 4
“Unliganded SHBG was shown to inhibit inflammatory cytokine expression in mouse macrophages and decrease cytokines and transcription factors involved in adipogenesis and triglyceride synthesis independent of sex steroids in mouse-derived 3T3-L1 adipocyte-like cells [152].”
Chang, X., Shih, C. C., Chen, J., Lee, A. S., Tan, P. B. O., Wang, L., Liu, J., Li, J., Yuan, J., Khor, C. C., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08675-8 · Cited by 4
“Previous studies have reported that low serum concentrations of SHBG are associated with an increased risk of T2D 26 – 28 .”
Yuan, Y., Cui, S., Hou, Y., Meng, X., Huang, Y., Xu, F., & Shi, W. (2025) · European journal of medical research · doi:10.1186/s40001-025-03470-x · Cited by 5
Sex steroids, SHBG and type 2 diabetes in women: what do we really know?
Verhoog, N. J. D., Africander, D., & Storbeck, K. (2026) · Diabetologia · doi:10.1007/s00125-025-06647-5 · Cited by 8
Cao, M., & Cui, B. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02222-1 · Cited by 6
“…in the hepatic lipogenesis, such as the adenosine triphosphate (ATP) citrate lyase (production of precursor for fatty acid), Acetyl-CoA-carboxylase and fatty acid synthase (further restriction of fatty acid synthesis) in the liver [78, 79], which could consequently reduce liver fat content.”
BackgroundSex hormone-binding globulin restrains hepatic fibrosis via inhibition of Tgfβ expression
Lee, S. R., Mukae, M., & Hong, E. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02569-2 · Cited by 4
Houston, J. M. I., Bourebaba, L., Bourebaba, N., Tomal, A., & Marycz, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1424873 · Cited by 5
Cooper, I. D., Petagine, L., Soto-Mota, A., Duraj, T., Seyfried, T. N., Lee, D. C., Cooper, N., & Kyriakidou, Y. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1731915 · Cited by 2
Protein pengikat hormon seks: sex hormone binding globulin (SHBG) dan aksi steroid seks
Guyansyah, A., & Parwanto, E. (2019) · Jurnal Biomedika dan Kesehatan · doi:10.18051/jbiomedkes.2019.v2.45-50 · Cited by 4
“34 Penelitian yang lain memperlihatkan bahwa kadar SHBG yang rendah berhubungan dengan resiko sindrom metabolik, antara lain diabetes, obesitas, dan penyakit kardiovaskuler.(35) Lebih khusus diperlihatkan bahwa kadar testosteron total dan testosteron bebas serta SHBG berdampak terhadap penyandang diabetes melitus tipe…”
BackgroundContessa, M., Ambrosio, M. R., Fabris, B., & Bernardi, S. (2026) · Obesity and Endocrinology · doi:10.1093/obendo/wjag003 · Cited by 1
IGF-1 and recovery in anorexia nervosa: evidence from population-based and clinical cohorts
Dani, C., Tarchi, L., Bonacchi, L., Haydar, S., Cassioli, E., Rossi, E., Fanelli, A., Logu, F. D., Nassini, R., Micali, N., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag211
Wang, Y., Xue, X., Usyk, M., Sharma, A., Anastos, K., Post, W. S., Hodis, H. N., Wang, Z., Witt, M. D., Rinaldo, C. R., et al. (2026) · Genome Medicine · doi:10.1186/s13073-026-01709-8 · Cited by 1
“…and lipid accumulation in adipocytes and macrophages, by markedly suppressing lipopolysaccharide-induced inflammatory cytokines production (e.g., MCP-1, TNF α , and IL-6) and phosphorylations of JNK and ERK [82], which may underlie the protective association of SHBG with cardiovascular health.”
Metabolism-dependent Vascular Pathophysiology in Adult Diseases
Kushiyama, A., Takahashi, M., Kushiyama, S., Kikuchi, T., & Asano, T. (2022) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.21-00176-3
Self-citation郭洪丹 (2010) · Journal of Tonghua Normal University
Advances of the Regulation of Sex-Hormone Globulin in Polycystic Ovary Syndrome
常, 小. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361341
Pranty-Weßelmann, A. I., Wruck, W., & Adjaye, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.12.548684
“On the other hand, SHBG exhibits anti-inflammatory effects in macrophages and adipocytes, however, SHBG expression in brain is not yet known [42].”
BackgroundChen, A., & Cai, Q. (2024) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70033
“Reduced levels of SHBG, a protein carrier with potential biological anti-inflammatory functions, modulate testosterone concentrations, and it is widely accepted that SHBG reduces the bioavailability and activity of TES [29] and predicts the risk of Type 2 diabetes and cardiovascular disease [30].”
Sex-specific associations of sex hormone binding globulin and risk of bladder cancer
Ou, J., Bi, H., Zhou, H., Zhang, Z., Duan, P., Yin, H., Zhou, Z., Xie, Z., Tian, X., Ye, J., et al. (2025) · Open Medicine · doi:10.1515/med-2025-1163
“SHBG inhibits in fl ammation in vitro , which is not altered by co-supple-mentation with testosterone or estradiol [26], supporting a pathway through in fl ammation.”
Goedecke, J. H., Kufe, C. N., Masemola, M., Lichaba, M., Seipone, I. D., Mendham, A. E., Gibson, H., Hawley, J. M., Selva, D. M., Magodoro, I. M., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf256 · Cited by 2
Pan, P., Liang, H., & Li, M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070494
“In addition, SHBG could markedly suppress lipopolysaccharide-induced inflammatory biomarkers in macrophages and adipocytes, such as monocyte chemoattractant protein-1, TNF α , and IL-6 [50], which have been re-ported to be closely related to stroke risk and prognosis [51,52].”
Bourebaba, N., Domagała, J., Pander, M., & Bourebaba, L. (2025) · Research Square · doi:10.21203/rs.3.rs-7698110/v1
Hang, D., He, X., Kværner, A. S., Chan, A. T., Wu, K., Ogino, S., Hu, Z., Shen, H., Giovannucci, E. L., & Song, M. (2021) · Figshare · doi:10.6084/m9.figshare.13655378
Zhu, R. Y., Wang, X., Ma, J., Shi, X., Zhang, Y., Jin, J., & Zhou, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1598164
“SHBG levels are low in obese PCOS patients (137), and positively correlated with HDL-C levels and negatively correlated with the occurrence of MetS (151).”
InfluentialAbu‐Zaid, A., Baradwan, S., Adly, H. M., Saleh, S. A. K., Alsehaimi, S. O., Albelwi, H., Alqarni, S. M. S., Jamjoom, M. Z., Alabdrabalamir, S., Alsabban, M., et al. (2026) · Scottish Medical Journal · doi:10.1177/00369330261457769 · Cited by 1
Zhang, J., van Dam, R. M., & Zhao, J. V. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101752
Cooper, I. D., Petagine, L., Cooper, N., Soto-Mota, A., Edwards, K., Kraev, I., Lange, S., & Kyriakidou, Y. (2026) · Clinical bioenergetics · doi:10.3390/clinbioenerg2040016
Metadata
- Authors
- Yamazaki, H., Kushiyama, A., Sakoda, H., Fujishiro, M., Yamamotoya, T., Nakatsu, Y., Kikuchi, T., Kaneko, S., Tanaka, H., & Asano, T.
- Affiliations
- IMSUT Hospital (JP)
- The Institute of Medical Science, Asahi Life Foundation (JP)
- University of Miyazaki (JP)
- Nihon University (JP)
- Hiroshima University (JP)
- University of Tokyo Hospital (JP)
- Corresponding author
- Asano, Tomoichiro
- ORCID
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2018-06-25
- Volume
- 2018
- Pages
- 1-12
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC6036814
- OpenAlex
- W2810907329
- Cited by
- 86
- References
- 60
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 14 · 2023: 17 · 2022: 12 · 2021: 9 · 2020: 7 · 2019: 5
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Institute for Adult Diseases Asahi Life Foundation (JP17K16158)
- Japan Society for the Promotion of Science (JP17K16158)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- sex hormone-binding globulin, metabolic syndrome, adipocytes, macrophages, inflammation, lipolysis, lipopolysaccharide, inflammatory cytokines, MCP-1, TNF-α, interleukin-6, JNK phosphorylation, ERK1/2 phosphorylation, 3T3-L1 adipocytes, testosterone, estradiol, lipid metabolism
- MeSH terms
- Animals, Anti-Inflammatory Agents, Estradiol, Humans, Inflammation, Lipolysis, Macrophages, Phosphorylation, Sex Hormone-Binding Globulin, Tumor Necrosis Factor-alpha, Interleukin-6, Adipocytes, Metabolic Syndrome, 3T3-L1 Cells, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.